Clinical Trial Update: A Study Evaluating the Safety of the Nasal Pump [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety of the OC-01 varenicline nasal spray for dry eye disease and keratoconjunctivitis sicca was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca

Drugs mentioned

• OC-01 (varenicline nasal spray)

Snippet

Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye, Kerato Conjunctivitis Sicca | Phase 4 | Status: TERMINATED | Results posted: 2025-05-02